{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:59:57Z","timestamp":1780941597920,"version":"3.54.1"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018973","name":"Lovely Professional University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.compbiomed.2026.111765","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T10:37:37Z","timestamp":1780137457000},"page":"111765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An integrated in silico approach to identify pyridine-based AChE and BChE inhibitors for Alzheimer's disease"],"prefix":"10.1016","volume":"212","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3903-2048","authenticated-orcid":false,"given":"Shivank","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9009-1561","authenticated-orcid":false,"given":"Vanktesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stalin","family":"Arulsamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8407-4693","authenticated-orcid":false,"given":"Shubham","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Wadhwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.compbiomed.2026.111765_bib1","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/alz.13809","article-title":"2024 alzheimer's disease facts and figures","volume":"20","year":"2024","journal-title":"Alzheimer's Dement."},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111765_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/neurosci6010005","article-title":"Neurodegenerative disorders in criminal offending and cognitive decline among aging inmates","volume":"6","author":"Veggi","year":"2025","journal-title":"NeuroSci"},{"key":"10.1016\/j.compbiomed.2026.111765_bib3","first-page":"1","article-title":"Monoamine alterations in Alzheimer's disease and their implications in comorbid neuropsychiatric symptoms","author":"Saggu","year":"2024","journal-title":"GeroScience"},{"issue":"4","key":"10.1016\/j.compbiomed.2026.111765_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/gpsych-2024-102020","article-title":"The China alzheimer report 2025","volume":"38","author":"Zhi","year":"2025","journal-title":"Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111765_bib5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13041-024-01118-1","article-title":"The duality of amyloid-\u03b2: its role in normal and Alzheimer's disease states","volume":"17","author":"Azargoonjahromi","year":"2024","journal-title":"Mol. Brain"},{"issue":"3","key":"10.1016\/j.compbiomed.2026.111765_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4103\/1673-5374.320970","article-title":"Pathological mechanisms and therapeutic strategies for Alzheimer's disease","volume":"17","author":"Ju","year":"2022","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111765_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00401-024-02790-2","article-title":"Inflammatory aspects of Alzheimer's disease","volume":"148","author":"Botella Lucena","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.compbiomed.2026.111765_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176230","article-title":"Trials and tribulations in alzheimer therapeutics","volume":"962","author":"Gharat","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.compbiomed.2026.111765_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70116","article-title":"Global, regional, and national burden of early\u2010onset alzheimer's disease and other dementias in young adults aged 40\u201364 years, 1990\u20132021: a population\u2010based study","volume":"32","author":"Zhang","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.compbiomed.2026.111765_bib10","series-title":"Incidence and Risk Factors of hospital-treated Infections in Persons with Alzheimer's Disease","author":"J\u00e4rvinen","year":"2025"},{"key":"10.1016\/j.compbiomed.2026.111765_bib11","series-title":"Sex Differences in Alzheimer's Disease Neuroimaging Biomarkers Among Cognitively Normal Older Adults","author":"Losinski","year":"2022"},{"issue":"5","key":"10.1016\/j.compbiomed.2026.111765_bib12","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3390\/biomedicines11051261","article-title":"Complexity of sex differences and their impact on Alzheimer's disease","volume":"11","author":"Kadlecova","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.compbiomed.2026.111765_bib13","series-title":"APOE4: Insights into Metabolic Changes in a Novel Mouse Model of Late-Onset Alzheimer's Disease","author":"Delatorre","year":"2024"},{"issue":"11","key":"10.1016\/j.compbiomed.2026.111765_bib14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41582-022-00714-w","article-title":"Gene\u2013environment interactions in alzheimer disease: the emerging role of epigenetics","volume":"18","author":"Migliore","year":"2022","journal-title":"Nat. Rev. Neurol."},{"issue":"14","key":"10.1016\/j.compbiomed.2026.111765_bib15","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.3390\/jcm13144130","article-title":"The brain\u2013gut axis, an important player in alzheimer and parkinson disease: a narrative review","volume":"13","author":"Caradonna","year":"2024","journal-title":"J. Clin. Med."},{"issue":"17","key":"10.1016\/j.compbiomed.2026.111765_bib16","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.3390\/ijms22179290","article-title":"Acetylcholinesterase inhibitors in the treatment of neurodegenerative diseases and the role of acetylcholinesterase in their pathogenesis","volume":"22","author":"Walczak-Nowicka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiomed.2026.111765_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in alzheimer's disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.compbiomed.2026.111765_bib18","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/molecules27061816","article-title":"Role of cholinergic signaling in Alzheimer's disease","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules"},{"issue":"30","key":"10.1016\/j.compbiomed.2026.111765_bib19","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.2174\/0929867324666170705123509","article-title":"Modulators of acetylcholinesterase activity: from alzheimer's disease to anti-cancer drugs","volume":"24","author":"Lazarevic-Pasti","year":"2017","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.compbiomed.2026.111765_bib20","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3390\/ijms22031273","article-title":"The cholinergic system, the adrenergic system and the neuropathology of Alzheimer's disease","volume":"22","author":"Bekdash","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiomed.2026.111765_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bcp.2018.01.044","article-title":"Cholinesterases and the fine line between poison and remedy","volume":"153","author":"Pope","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.compbiomed.2026.111765_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113949","article-title":"Therapeutic potential of quinazoline derivatives for alzheimer's disease: a comprehensive review","volume":"227","author":"Haghighijoo","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2026.111765_bib23","article-title":"Natural acetylcholinesterase inhibitors: a multi-targeted therapeutic potential in alzheimer's disease","author":"Gajendra","year":"2024","journal-title":"Europ. J. Med. Chem. Rep."},{"key":"10.1016\/j.compbiomed.2026.111765_bib24","series-title":"Recent Developments in the Synthesis and Applications of Pyridines","first-page":"69","article-title":"Synthetic strategies of functionalized pyridines and their therapeutic potential as multifunctional anti-alzheimer's agents","author":"Shaik","year":"2023"},{"issue":"12","key":"10.1016\/j.compbiomed.2026.111765_bib25","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1080\/17460441.2023.2264766","article-title":"Advances in the discovery of heterocyclic-based drugs against Alzheimer's disease","volume":"18","author":"S\u00e1nchez","year":"2023","journal-title":"Expert Opin. Drug Discov."},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111765_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-020-00189-z","article-title":"Current understanding of metal ions in the pathogenesis of Alzheimer\u2019s disease","volume":"9","author":"Wang","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.compbiomed.2026.111765_bib27","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s00204-019-02538-y","article-title":"Management of oxidative stress and other pathologies in Alzheimer's disease","volume":"93","author":"Simunkova","year":"2019","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111765_bib28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.compbiomed.2026.111765_bib29","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.2147\/DDDT.S329547","article-title":"The expanding role of pyridine and dihydropyridine scaffolds in drug design","author":"Ling","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"issue":"31","key":"10.1016\/j.compbiomed.2026.111765_bib30","doi-asserted-by":"crossref","first-page":"19764","DOI":"10.1039\/D2RA03081K","article-title":"Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase","volume":"12","author":"Obaid","year":"2022","journal-title":"RSC Adv."},{"issue":"8","key":"10.1016\/j.compbiomed.2026.111765_bib31","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3390\/molecules22081300","article-title":"Ultrafast and slow cholinergic transmission. Different involvement of acetylcholinesterase molecular forms","volume":"22","author":"Dunant","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.compbiomed.2026.111765_bib32","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.toxrep.2021.06.017","article-title":"Subchronic neurotoxicity of diazinon in albino mice: impact of oxidative stress, AChE activity, and gene expression disturbances in the cerebral cortex and hippocampus on mood, spatial learning, and memory function","volume":"8","author":"Karimani","year":"2021","journal-title":"Toxicol. Rep."},{"issue":"8","key":"10.1016\/j.compbiomed.2026.111765_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.31274","article-title":"New paradigms in the study of the cholinergic system and metabolic diseases: acetyl\u2010and\u2010butyrylcholinesterase","volume":"239","author":"Villeda\u2010Gonz\u00e1lez","year":"2024","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.compbiomed.2026.111765_bib34","first-page":"1","article-title":"A systems biology approach reveals dual neurotherapeutic mechanisms of Dioscorea bulbifera in Alzheimer's disease via estrogen signaling and cholinergic modulation","author":"Chowdhury","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"2","key":"10.1016\/j.compbiomed.2026.111765_bib35","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/med.21745","article-title":"Structure and therapeutic uses of butyrylcholinesterase: application in detoxification, alzheimer's disease, and fat metabolism","volume":"41","author":"Xing","year":"2021","journal-title":"Med. Res. Rev."},{"issue":"6","key":"10.1016\/j.compbiomed.2026.111765_bib36","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4155\/fmc-2016-0003","article-title":"Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics","volume":"8","author":"Rosini","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.compbiomed.2026.111765_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1193590","article-title":"Therapeutic effects of phlorotannins in the treatment of neurodegenerative disorders","volume":"16","author":"Kwon","year":"2023","journal-title":"Front. Mol. Neurosci."},{"issue":"7","key":"10.1016\/j.compbiomed.2026.111765_bib38","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1093\/brain\/awac096","article-title":"Reimagining cholinergic therapy for Alzheimer's disease","volume":"145","author":"Giacobini","year":"2022","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.compbiomed.2026.111765_bib39","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3390\/biom9100592","article-title":"Butyrylcholinesterase protein ends in the pathogenesis of Alzheimer's disease\u2014could BCHE genotyping be helpful in Alzheimer's therapy?","volume":"9","author":"Jasiecki","year":"2019","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.compbiomed.2026.111765_bib40","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/1567205017666200422152440","article-title":"Genetic editing and pharmacogenetics in current and future therapy of neurocognitive disorders","volume":"17","author":"Prendecki","year":"2020","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.compbiomed.2026.111765_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138228","article-title":"Development of promising acetylcholinesterase and butyrylcholinesterase inhibitors: synthesis, in vitro and in silico approaches of pyridine derived fused bis-oxadiazole and bis-thiadiazole derivatives","volume":"1310","author":"Hussain","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"11","key":"10.1016\/j.compbiomed.2026.111765_bib42","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.3390\/genes14112048","article-title":"Pharmacogenomics of dementia: personalizing the treatment of cognitive and neuropsychiatric symptoms","volume":"14","author":"Vuic","year":"2023","journal-title":"Genes"},{"issue":"11\u201312","key":"10.1016\/j.compbiomed.2026.111765_bib43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.18071\/isz.74.0379","article-title":"Cholinesterase inhibitors and memantine for the treatment of alzheimer and non-Alzheimer dementias","volume":"74","author":"Bal\u00e1zs","year":"2021","journal-title":"Ideggyogy Sz"},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111765_bib44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.emc.2023.06.022","article-title":"Physiologic effects of substance use","volume":"42","author":"Murray","year":"2024","journal-title":"Emerg. Med. Clin."},{"issue":"6532","key":"10.1016\/j.compbiomed.2026.111765_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/science.abb8255","article-title":"Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies","volume":"371","author":"Chang","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.compbiomed.2026.111765_bib46","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/B978-0-323-91221-1.00009-9","article-title":"Recent developments in the synthesis of pyridine analogues as a potent anti-alzheimer's therapeutic leads","author":"Rammohan","year":"2023","journal-title":"Recen. Developm. Synthes. Appl. Pyridin."},{"key":"10.1016\/j.compbiomed.2026.111765_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131018","article-title":"Fused thiophene as a privileged scaffold: a review on anti-alzheimer's disease potentials via targeting cholinesterases, monoamine oxidases, glycogen synthase kinase-3, and A\u03b2 aggregation","author":"Kassab","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111765_bib48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer's disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"6","key":"10.1016\/j.compbiomed.2026.111765_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202000924","article-title":"Design, synthesis, and molecular docking of some novel tacrine based Cyclopentapyranopyridine- and Tetrahydropyranoquinoline-Kojic acid derivatives as anti-acetylcholinesterase agents","volume":"18","author":"Babaee","year":"2021","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.compbiomed.2026.111765_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105390","article-title":"Interest of novel N-alkylpyridinium-indolizine hybrids in the field of alzheimer's disease: synthesis, characterization and evaluation of antioxidant activity, cholinesterase inhibition, and amyloid fibrillation interference","volume":"116","author":"Baussanne","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"21","key":"10.1016\/j.compbiomed.2026.111765_bib51","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1021\/acschemneuro.1c00485","article-title":"New pyrimidine and pyridine derivatives as multitarget cholinesterase inhibitors: design, synthesis, and in vitro and in cellulo evaluation","volume":"12","author":"Bortolami","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.compbiomed.2026.111765_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.895483","article-title":"Novel coumarin-pyridine hybrids as potent multi-target directed ligands aiming at symptoms of alzheimer's disease","volume":"10","author":"Babaei","year":"2022","journal-title":"Front. Chem."},{"issue":"22","key":"10.1016\/j.compbiomed.2026.111765_bib53","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2026.111765_bib54","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ejmech.2019.02.021","article-title":"Novel tacrine-tryptophan hybrids: multi-target directed ligands as potential treatment for alzheimer's disease","volume":"168","author":"Chalupova","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2026.111765_bib55","first-page":"455","article-title":"Software news and update AutoDock vina: improving the speed and accuracy of docking with a new scoring function","volume":"31","author":"Trott","year":"2009","journal-title":"Effic. Optim. Multithread."},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111765_bib56","doi-asserted-by":"crossref","DOI":"10.1186\/s13321-015-0067-5","article-title":"Calculating an optimal box size for ligand docking and virtual screening against experimental and predicted binding pockets","volume":"7","author":"Feinstein","year":"2015","journal-title":"J. Cheminf."},{"key":"10.1016\/j.compbiomed.2026.111765_bib57","doi-asserted-by":"crossref","first-page":"28","DOI":"10.22159\/ajpcr.2017.v10s4.21332","article-title":"Design and molecular docking studies of novel antimicrobial peptides using autodock molecular docking software","author":"Kaur","year":"2017","journal-title":"Asian J. Pharmaceut. Clin. Res."},{"issue":"14","key":"10.1016\/j.compbiomed.2026.111765_bib58","doi-asserted-by":"crossref","first-page":"76","DOI":"10.22159\/ajpcr.2018.v11s2.28587","article-title":"A comparative study of stereochemical effects of anti-prostate agents by molecular docking","volume":"11","author":"Osanyinpeju","year":"2018","journal-title":"Asian J. Pharmaceut. Clin. Res."},{"issue":"2","key":"10.1016\/j.compbiomed.2026.111765_bib59","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1573409914666181019165821","article-title":"In silico molecular docking study to search new SGLT2 inhibitor based on dioxabicyclo [3.2. 1] octane scaffold","volume":"16","author":"Kumar","year":"2020","journal-title":"Curr. Comput. Aided Drug Des."},{"issue":"5","key":"10.1016\/j.compbiomed.2026.111765_bib60","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2174\/1573409919666230626113346","article-title":"A rationalized approach to design and discover novel non-steroidal derivatives through computational aid for the treatment of prostate cancer","volume":"20","author":"Kumar","year":"2024","journal-title":"Curr. Comput. Aided Drug Des."},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111765_bib61","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/0115743624270694231213095103","article-title":"Discovery of \u03b2-carboline based derivatives through computational aid for the treatment of leishmania","volume":"19","author":"Mwamafupa","year":"2024","journal-title":"Curr. Signal Transduct. Ther."},{"issue":"3","key":"10.1016\/j.compbiomed.2026.111765_bib62","doi-asserted-by":"crossref","first-page":"74","DOI":"10.33435\/tcandtc.1386285","article-title":"Molecular design and virtual screening of novel heterocyclic derivatives as glucokinase activators","volume":"8","author":"Mehra","year":"2024","journal-title":"Turkish Computat. Theoret. Chem."},{"issue":"5","key":"10.1016\/j.compbiomed.2026.111765_bib63","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2174\/0113892002321919240801065905","article-title":"Prediction of protein-drug interactions, pharmacophore modeling, and toxicokinetics of novel leads for type 2 diabetes treatment","volume":"25","author":"Mehra","year":"2024","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.compbiomed.2026.111765_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.107029","article-title":"Synthesis, molecular docking and biological evaluation of 1, 2, 4-oxadiazole based novel non-steroidal derivatives against prostate cancer","volume":"143","author":"Kumar","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.compbiomed.2026.111765_bib65","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2174\/1570180819666220523093435","article-title":"Virtual screening, molecular docking, and physiochemical analysis of novel 1, 3-diphenyl-2-propene-1-one as dual COX-2\/5-LOX inhibitors","volume":"21","author":"Mittal","year":"2024","journal-title":"Lett. Drug Des. Discovery"},{"key":"10.1016\/j.compbiomed.2026.111765_bib66","first-page":"1","article-title":"Design, synthesis and biological evaluation of non-glucosidal based 1, 3, 4-thiadiazoles as SGLT-2 inhibitors","author":"Sharma","year":"2025","journal-title":"Future Med. Chem."},{"issue":"14","key":"10.1016\/j.compbiomed.2026.111765_bib67","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2026.111765_bib68","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1023\/A:1007996124545","article-title":"Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes","volume":"11","author":"Eldridge","year":"1997","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.compbiomed.2026.111765_bib69","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s008940050096","article-title":"SCORE: a new empirical method for estimating the binding affinity of a protein-ligand complex","volume":"4","author":"Wang","year":"1998","journal-title":"Mol. Mod. Ann."},{"issue":"7","key":"10.1016\/j.compbiomed.2026.111765_bib70","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/ci7004669","article-title":"AIScore chemically diverse empirical scoring function employing quantum chemical binding energies of hydrogen-bonded complexes","volume":"48","author":"Raub","year":"2008","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111765_bib71","first-page":"82","article-title":"Pymol: an open-source molecular graphics tool","volume":"40","author":"DeLano","year":"2002","journal-title":"CCP4 Newsl. Protein Crystallogr."},{"key":"10.1016\/j.compbiomed.2026.111765_bib72","volume":"vol. 2","author":"Visualizer","year":"2005"},{"issue":"16","key":"10.1016\/j.compbiomed.2026.111765_bib73","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"3","key":"10.1016\/j.compbiomed.2026.111765_bib74","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.compbiomed.2026.111765_bib75","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1006\/jmbi.1996.0477","article-title":"A fast flexible docking method using an incremental construction algorithm","volume":"261","author":"Rarey","year":"1996","journal-title":"J. Mol. Biol."},{"issue":"9","key":"10.1016\/j.compbiomed.2026.111765_bib76","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2026.111765_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"W1","key":"10.1016\/j.compbiomed.2026.111765_bib78","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.compbiomed.2026.111765_bib79","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"issue":"12","key":"10.1016\/j.compbiomed.2026.111765_bib80","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"issue":"7","key":"10.1016\/j.compbiomed.2026.111765_bib81","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"G_mmpbsa A GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","year":"2014","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"10.1016\/j.compbiomed.2026.111765_bib82","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/minf.201100135","article-title":"Free energy calculations by the molecular mechanics poisson\u2212 boltzmann surface area method","volume":"31","author":"Homeyer","year":"2012","journal-title":"Mol. Inf."},{"issue":"11","key":"10.1016\/j.compbiomed.2026.111765_bib83","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","article-title":"ZINC 15--Ligand discovery for everyone","volume":"55","author":"Sterling","year":"2015","journal-title":"J. Chem. Inf. Model."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001048252600329X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001048252600329X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:29:17Z","timestamp":1780939757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001048252600329X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":83,"alternative-id":["S001048252600329X"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2026.111765","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An integrated in silico approach to identify pyridine-based AChE and BChE inhibitors for Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2026.111765","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111765"}}